On July 9, 2026, the Financial Times of the UK cited people familiar with the matter as reporting that Blackstone and TPG are looking to sell Hologic’s Surgical Unit for more than $4 billion (approximately 27.2‑billion Chinese yuan) and have engaged advisors to push forward with the deal.
Recently, Nature published a groundbreaking medical study, in which an engineering and surgical team from the University of California, San Diego (UCSD) accomplished the world‑first‑ever in‑vivo surgical trial performed by a remotely operated humanoid robot.
On July 8, Johnson & Johnson officially announced that its Dual‑Energy THERMOCOOL SMARTTOUCH‑SF (DE‑ST‑SF) dual‑energy ablation platform has secured US FDA clearance for market launch. It marks the world’s first interventional device enabling seamless switching between radio‑frequency ablation (RF)
On July 7, 2026, Japanese surgical robotics company Medicaroid officially announced that its self-developed Hinotori laparoscopic surgical robot has successfully obtained the EU CE-MDR certification.
In the first half of 2026, the commercialization of domestic surgical robots is entering a critical stage of accelerated rollout.
According to an announcement from Jiejing Medical, the company’s single-use electronic upper and lower gastrointestinal imaging catheters have successfully passed review by the Liaoning Provincial Drug Administration and officially obtained Class II Medical Device Registration Certificates.
Both organisations plan to use Olympus' network and EndoRobotics' expertise to make the solutions globally available.
New data on the pulsed-field ablation (PFA) device class debuts at HRS 2026 as the field catches the eye of several large medtech companies.
UT Austin researchers developed a dual-light 3D printing method using resin that creates objects with both soft and hard properties, promising advances in prosthetics and medical devices that better interface with the human body.
The absence of an alert provides limited reassurance, particularly for older adults or people with an elevated risk of high blood pressure, according to the study's authors.
Virtual care provider Vida Health integrates Oura Ring biometric data to drive earlier clinical interventions, improve care plan adherence, and predict metabolic health risks.
CEO Mike Mahoney told investors that the lowered forecast reflects challenges for several businesses, including electrophysiology and Watchman.
Following two recent Council decisions authorising the signature of the EU–Mercosur Partnership Agreement (EMPA) and the Interim Trade Agreement (iTA
Europe: Joint industry statement on the new Packaging and Packaging Waste Regulation
Jack Heslin of Creatz3D discusses AI and 3D printing's potential for patient-specific devices while addressing manufacturability gaps, regulatory challenges, and the risks of over-relying on AI decision-making.
OsseoLabs' implants include surgical design and planning with assistance from artificial intelligence.
The system has been lauded as one of the next best things in medtech for its approach to mark breast cancer lesions for surgical removal.
Boston Scientific's recall highlights high impedance risks in medical devices. Understand the meaning, causes, and possible solutions.
Trivia Tuesday: Ripped from the headlines 34 years before its time, what show eerily predicted Boston Scientific’s pacemaker battery problem?
